Arnt Schellekens
Arnt Schellekens
Radboudumc, Donders Institute for Brain, Cognition and Behavior
Verified email at
Cited by
Cited by
Disruption of reward processing in addiction: an image-based meta-analysis of functional magnetic resonance imaging studies
M Luijten, AF Schellekens, S Kühn, MWJ Machielse, G Sescousse
JAMA psychiatry 74 (4), 387-398, 2017
Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning
ME van der Schaaf, MR van Schouwenburg, DEM Geurts, ...
Cerebral Cortex 24 (3), 633-642, 2014
Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment
AFA Schellekens, CAJ De Jong, JK Buitelaar, RJ Verkes
European Psychiatry 30 (1), 128-136, 2015
Disrupted sensorimotor gating due to mental fatigue: preliminary evidence
D van der Linden, SAA Massar, AFA Schellekens, BA Ellenbroek, ...
International journal of psychophysiology 62 (1), 168-174, 2006
International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder
CL Crunelle, W van den Brink, F Moggi, M Konstenius, J Franck, FR Levin, ...
European addiction research 24 (1), 43-51, 2018
Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes
AFA Schellekens, B Franke, B Ellenbroek, A Cools, CAJ de Jong, ...
Archives of general psychiatry 69 (4), 339-348, 2012
Alcohol dependence and anxiety increase error‐related brain activity
AFA Schellekens, ERA De Bruijn, CAA Van Lankveld, W Hulstijn, ...
Addiction 105 (11), 1928-1934, 2010
COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence
AFA Schellekens, B Franke, B Ellenbroek, A Cools, CAJ de Jong, ...
Addiction biology 18 (2), 344-356, 2013
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study
GA Kalkman, C Kramers, RT van Dongen, W van den Brink, ...
The Lancet Public Health 4 (10), e498-e505, 2019
The role of the habenula in the transition from reward to misery in substance use and mood disorders
A Batalla, JR Homberg, TV Lipina, G Sescousse, M Luijten, SA Ivanova, ...
Neuroscience & Biobehavioral Reviews 80, 276-285, 2017
Effectiveness and organization of addiction medicine training across the globe
AP Ayu, AFA Schellekens, S Iskandar, L Pinxten, CAJ De Jong
European Addiction Research 21 (5), 223-239, 2015
Pharmacological treatment in γ-hydroxybutyrate (GHB) and γ-butyrolactone (GBL) dependence: detoxification and relapse prevention
RM Kamal, MS van Noorden, W Wannet, H Beurmanjer, BAG Dijkstra, ...
CNS drugs 31 (1), 51-64, 2017
Effect of apomorphine on cognitive performance and sensorimotor gating in humans
AFA Schellekens, KP Grootens, C Neef, KLL Movig, JK Buitelaar, ...
Psychopharmacology 207 (4), 559-569, 2010
Psilocybin for treating substance use disorders?
BTH De Veen, AFA Schellekens, MMM Verheij, JR Homberg
Expert review of neurotherapeutics 17 (2), 203-212, 2017
The level of alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment
HA de Haan, AFA Schellekens, J van der Palen, RJ Verkes, JK Buitelaar, ...
The American Journal of Drug and Alcohol Abuse 38 (4), 299-304, 2012
Ibogaine and addiction in the animal model, a systematic review and meta-analysis
M Belgers, M Leenaars, JR Homberg, M Ritskes-Hoitinga, ...
Translational psychiatry 6 (5), e826-e826, 2016
Anatomical connection strength predicts dopaminergic drug effects on fronto-striatal function
MR van Schouwenburg, MP Zwiers, ME van der Schaaf, DEM Geurts, ...
Psychopharmacology 227 (3), 521-531, 2013
Improvement of depression and anxiety after discontinuation of long-term efavirenz treatment
K M Mothapo, A Schellekens, R van Crevel, M Keuter, K Grintjes-Huisman, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015
Rethinking the risk–benefit ratio of efavirenz in HIV-infected children
L Van de Wijer, AFA Schellekens, DM Burger, JR Homberg, Q de Mast, ...
The Lancet Infectious Diseases 16 (5), e76-e81, 2016
Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring
LC Martial, RE Aarnoutse, M Mulder, A Schellekens, RJM Brüggemann, ...
European Neuropsychopharmacology 27 (3), 205-216, 2017
The system can't perform the operation now. Try again later.
Articles 1–20